R&D / revenue moved 882 bp higher
R&D / revenue changed +882 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
R&D / revenue changed +882 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -7.9% from the comparable as-filed period.
Cash / debt changed +30888 basis points from the comparable as-filed period.
Current ratio changed +205.4% from the comparable as-filed period.
Working capital / assets changed +3876 basis points from the comparable as-filed period.
Debt / revenue changed +5585 basis points from the comparable as-filed period.
Receivables / revenue changed -5159 basis points from the comparable as-filed period.
Operating cash-flow margin changed -9206 basis points from the comparable as-filed period.
Inventory changed -11.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Debt / assets changed +83 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current long-term debt changed +0.2% from the comparable as-filed period.
Gross profit changed -1.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.